LILRA3
LILRA3 (leukocyte immunoglobulin like receptor A3, also known as CD85e, LIR-4, ILT6, HM31 and HM43) is a secreted member of the leukocyte immunoglobulin-like receptor family. It acts as a soluble receptor for class I MHC antigens. Browse Assay Genie's current range of LILRA3 research reagents below, or read on for the biology behind the target.
LILRA3 functions as a soluble receptor for class I MHC antigens. It binds both classical and non-classical HLA class I molecules, although with reduced affinities compared with LILRB1 or LILRB2. UniProt also reports that it binds with high affinity to the surface of monocytes, leading to abolition of LPS-induced TNF production by these cells.
The LILRA3 gene encodes a member of a family of immunoreceptors expressed predominantly in monocytes and B cells, and at lower levels in dendritic cells and natural killer cells. Unlike other members of the family, the encoded protein lacks a transmembrane region, which is consistent with its secreted localisation. Alternatively spliced transcript variants encoding different isoforms have been described.
The LILRA3 gene lies within a cluster of related genes on chromosome 19 and is polymorphic in human populations, with many individuals carrying a deletion of this genomic region. HGNC places the protein in the CD molecules group and among the activating leukocyte immunoglobulin like receptors. Its previous name, leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3, reflects the absence of the transmembrane domain.
LILRA3 binds classical and non-classical HLA class I molecules as a soluble receptor, making it a useful subject for studying MHC class I recognition.
LILRA3 binds the monocyte surface with high affinity and abolishes LPS-induced TNF production, linking it to the regulation of monocyte responses.
Its reduced HLA class I affinity relative to LILRB1 and LILRB2 allows comparison of binding behaviour across leukocyte immunoglobulin-like receptors.
The gene is polymorphic and often deleted in individuals, which makes it relevant to studies of genetic variation in the chromosome 19 receptor cluster.
LILRA3 acts as a soluble receptor for class I MHC antigens. It binds classical and non-classical HLA class I molecules with lower affinity than LILRB1 or LILRB2, and binds the monocyte surface with high affinity, which abolishes LPS-induced TNF production by monocytes.
LILRA3 is also called CD85e, LIR-4, LIR4, ILT6, HM31 and HM43. Its previous HGNC name described it as a subfamily A member without a TM domain. Alternatively spliced transcript variants encoding different isoforms have been reported.
No. The LILRA3 gene is polymorphic in human populations, and many individuals carry a deletion of this genomic region within a cluster of related genes on chromosome 19. No mouse or rat ortholog is listed in the data here; check the datasheet of any product for its validated reactivity.
Other activating leukocyte immunoglobulin-like receptors in the same family, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8N6C8; product specifications from Assay Genie datasheets.